BNTX
Price
$120.54
Change
+$5.71 (+4.97%)
Updated
Apr 24 closing price
Capitalization
28.98B
10 days until earnings call
CVAC
Price
$3.26
Change
+$0.09 (+2.84%)
Updated
Apr 24 closing price
Capitalization
734.01M
26 days until earnings call
Ad is loading...

BNTX vs CVAC

Header iconBNTX vs CVAC Comparison
Open Charts BNTX vs CVACBanner chart's image
BioNTech SE American Depositary Share
Price$120.54
Change+$5.71 (+4.97%)
Volume$1.51M
Capitalization28.98B
CureVac
Price$3.26
Change+$0.09 (+2.84%)
Volume$284.51K
Capitalization734.01M
BNTX vs CVAC Comparison Chart
Loading...
BNTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
CVAC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
BNTX vs. CVAC commentary
Apr 25, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BNTX is a StrongBuy and CVAC is a Hold.

Ad is loading...
COMPARISON
Comparison
Apr 25, 2025
Stock price -- (BNTX: $120.54 vs. CVAC: $3.26)
Brand notoriety: BNTX and CVAC are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: BNTX: 145% vs. CVAC: 45%
Market capitalization -- BNTX: $28.98B vs. CVAC: $734.01M
BNTX [@Biotechnology] is valued at $28.98B. CVAC’s [@Biotechnology] market capitalization is $734.01M. The market cap for tickers in the [@Biotechnology] industry ranges from $275.91B to $0. The average market capitalization across the [@Biotechnology] industry is $2.09B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BNTX’s FA Score shows that 2 FA rating(s) are green whileCVAC’s FA Score has 0 green FA rating(s).

  • BNTX’s FA Score: 2 green, 3 red.
  • CVAC’s FA Score: 0 green, 5 red.
According to our system of comparison, BNTX is a better buy in the long-term than CVAC.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BNTX’s TA Score shows that 4 TA indicator(s) are bullish while CVAC’s TA Score has 5 bullish TA indicator(s).

  • BNTX’s TA Score: 4 bullish, 6 bearish.
  • CVAC’s TA Score: 5 bullish, 5 bearish.
According to our system of comparison, CVAC is a better buy in the short-term than BNTX.

Price Growth

BNTX (@Biotechnology) experienced а +22.05% price change this week, while CVAC (@Biotechnology) price change was +4.49% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +8.06%. For the same industry, the average monthly price growth was -5.30%, and the average quarterly price growth was -11.62%.

Reported Earning Dates

BNTX is expected to report earnings on Aug 04, 2025.

CVAC is expected to report earnings on Aug 14, 2025.

Industries' Descriptions

@Biotechnology (+8.06% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
BNTX($29B) has a higher market cap than CVAC($734M). BNTX has higher P/E ratio than CVAC: BNTX (161.76) vs CVAC (3.99). BNTX YTD gains are higher at: 5.783 vs. CVAC (-4.399). CVAC has higher annual earnings (EBITDA): 166M vs. BNTX (-367.1M). BNTX has more cash in the bank: 16.8B vs. CVAC (555M). CVAC has less debt than BNTX: CVAC (40.1M) vs BNTX (254M). BNTX has higher revenues than CVAC: BNTX (2.75B) vs CVAC (543M).
BNTXCVACBNTX / CVAC
Capitalization29B734M3,951%
EBITDA-367.1M166M-221%
Gain YTD5.783-4.399-131%
P/E Ratio161.763.994,055%
Revenue2.75B543M507%
Total Cash16.8B555M3,027%
Total Debt254M40.1M633%
TECHNICAL ANALYSIS
Technical Analysis
BNTXCVAC
RSI
ODDS (%)
Bearish Trend 1 day ago
86%
N/A
Stochastic
ODDS (%)
Bearish Trend 1 day ago
79%
Bearish Trend 1 day ago
87%
Momentum
ODDS (%)
Bullish Trend 1 day ago
76%
Bullish Trend 1 day ago
71%
MACD
ODDS (%)
Bullish Trend 1 day ago
81%
Bullish Trend 1 day ago
81%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
74%
Bullish Trend 1 day ago
77%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
74%
Bullish Trend 1 day ago
70%
Advances
ODDS (%)
Bullish Trend 1 day ago
77%
Bullish Trend 11 days ago
77%
Declines
ODDS (%)
Bearish Trend 9 days ago
81%
Bearish Trend 2 days ago
88%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
85%
Bearish Trend 1 day ago
90%
Aroon
ODDS (%)
Bearish Trend 1 day ago
83%
Bearish Trend 1 day ago
89%
View a ticker or compare two or three
Ad is loading...
BNTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
CVAC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
FIGRX50.54N/A
N/A
Fidelity International Discovery
FTDZX118.04N/A
N/A
Franklin Biotechnology Discovery Adv
DIAYX27.25N/A
N/A
Diamond Hill Long-Short Y
SDVGX14.60N/A
N/A
Sit Dividend Growth I
CAEAX24.43N/A
N/A
Columbia Acorn European A

BNTX and

Correlation & Price change

A.I.dvisor indicates that over the last year, BNTX has been loosely correlated with MRNA. These tickers have moved in lockstep 54% of the time. This A.I.-generated data suggests there is some statistical probability that if BNTX jumps, then MRNA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BNTX
1D Price
Change %
BNTX100%
+4.97%
MRNA - BNTX
54%
Loosely correlated
+3.20%
TIL - BNTX
51%
Loosely correlated
-4.43%
CVAC - BNTX
48%
Loosely correlated
+2.84%
ARCT - BNTX
46%
Loosely correlated
+1.90%
AXON - BNTX
43%
Loosely correlated
+2.39%
More

CVAC and

Correlation & Price change

A.I.dvisor indicates that over the last year, CVAC has been loosely correlated with BNTX. These tickers have moved in lockstep 48% of the time. This A.I.-generated data suggests there is some statistical probability that if CVAC jumps, then BNTX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CVAC
1D Price
Change %
CVAC100%
+2.84%
BNTX - CVAC
48%
Loosely correlated
+4.97%
MRNA - CVAC
46%
Loosely correlated
+3.20%
ARCT - CVAC
42%
Loosely correlated
+1.90%
MDGL - CVAC
42%
Loosely correlated
+3.61%
AXON - CVAC
39%
Loosely correlated
+2.39%
More